CLSI M39 A4 : 4ED 2014

Abstract
Committee Membership
Foreword
1 Scope
2 Introduction
3 Standard Precautions
4 Terminology
5 Information System Design
Part I - The Routine Cumulative Antibiogram
6 Data Analysis
7 Data Presentation
8 Use of Cumulative Antimicrobial Susceptibility Reports
9 Limitations of Data, Data Analysis, and Data Presentation
10 Statistical Considerations
Part II - The Enhanced Antibiogram
11 Stratifying Cumulative Antibiogram data by Various
   Parameters
12 Supplemental Analyses of Multidrug-Resistant Organisms
13 Examining Percent Susceptible for Combinations of
   Antimicrobial Agents
14 Analysis of Susceptibility Profiles of Select Organisms
15 Calculating Percent Susceptible on Select Groups of
   Organisms
16 Graphic Presentation of Percent Susceptible Data
   to Illustrate Trends in Susceptibility
17 Local Cumulative Antibiograms vs External Antibiograms
   (eg, Data From External Surveillance Programs)
References
Additional References
Appendix A - Suggestions for Confirmation of Resistant (R),
             Intermediate (I), or Nonsusceptible (NS)
             Antimicrobial Susceptibility Test Results
             and Organism Identification
Appendix B - Rationale Behind the 'First Isolate per Patient'
             Analysis Recommendation
Appendix C - Example of Using a Line Listing to Verify
             Susceptibility Rates Determined by the
             Analysis Software
Appendix D - Examples of Supplemental Analyses - Stratifying
             Cumulative Antibiogram Data by Various Parameters
Appendix E1 - Cumulative Antimicrobial Susceptibility Report
              Example - Antimicrobial Agents Listed
              Alphabetically (Hypothetical Data)
Appendix E2 - Cumulative Antimicrobial Susceptibility Report -
              Antimicrobial Agents Listed by Class
              (Hypothetical Data)
Appendix F - Examples of Graphs to Illustrate Trends in
             Susceptibility
Appendix G - Steps for Presenting Local Cumulative Antibiogram
             Report to Health Care Professionals
Appendix H - Statistical Methods for Examining Percent
             Susceptible
Appendix I - Glossaries of Beta-Lactams and Non-Beta-Lactams:
             Class and Subclass Designation and Generic Name,
             and Abbreviations/Routes of Administration/Drug
             Class for Antimicrobial Agents
Appendix J - Intrinsic Resistance
The Quality Management System Approach
Related CLSI Reference Materials